Select your language/region

Global English
US English
Swedish

English
Swedish
US

Search

Sign in

Our products
- ASTar
  ASTar is a valuable tool in both the lab and the clinic. Learn more about how ASTar can help your setting by selecting from the list on the right.
  Learn about ASTar
- ASTar in the lab
  - ASTar in the clinic
  - ASTar kit
- Connect with us
Sepsis
Antimicrobial resistance
About us
- About us
  Q-linea is a world-class company on a mission to improve sepsis treatment and safeguard the effectiveness of antibiotics for generations to come. Read more about how our humble beginnings in a small city in Sweden helped shape who we are today.
  Read more about us
- News and events
Investor relations
- Investor relations
  Information to the capital market about Q-linea, our operations and development
  More about investor relations
- The share
- Financial Calendar
  - Reports and presentations
  - Press releases
- Corporate Governance
- Rights issue 2025
  - About the rights issue
  - Press releases about the rights issue
Contact us
- Contact and directions
  We are always interested in hearing from you. Please contact us with any queries. Or if you just want to see more of our happy faces, find downloadable images of us in our image bank.
  Go to contact and directions
- Whistleblowing
Career

Support zone
Sign in

Support zone

Annual General Meeting 2025

Annual General Meeting 2025

Event information

Date

26/06/2025

Time

15:00

Add to calendar

Back to calendar >

Q-linea is an
ISO 13485:2016 certified
company.

Contact us

Dag Hammarskjölds väg 52 A

SE-752 37 Uppsala

SWEDEN

contact@qlinea.com

Code of Conduct

Subscribe

Subscribe to our company newsletter and/or IR-related information.

Subscribe to newsletter IR-related information

Subscribe

Yes, please keep me updated on Q-linea news, events and offers.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

I allow Q-linea to store and process my personal information (see Q-linea.com’s privacy policy).